Coronavirus Update: 'Positive News' Imminent From Oxford and AstraZeneca Vaccine

Plus: Favipiravir Price Cut And New Approval In India

More news from across the sector, including Novartis's non-profit pledge on medicines and Zydus Cadila commencing Phase I vaccine trial.

Old Road Campus
The vaccine is being developed by Oxford's Jenner Institute in collaboration with AstraZeneca

The University of Oxford is expected to release an update on the COVID-19 vaccine it is co-developing with AstraZeneca PLC, with “positive news” anticipated from Phase I trials.

Named AZD1222, the adenovirus vaccine candidate is almost certainly the most advanced candidate in the fight against SARS-CoV-2, thanks to...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip